Ethiopia Launches Hepatitis B Birth Dose Vaccine to Protect Newborns (2026)

A Silent Killer Stopped in Its Tracks: Ethiopia's Bold Move Against Hepatitis B

Imagine a disease so insidious that it can silently pass from mother to child, condemning newborns to a lifetime of illness. This is the grim reality of Hepatitis B, a virus that has long plagued Ethiopia. But here's the game-changer: Ethiopia is fighting back with a powerful weapon – the Hepatitis B Birth Dose (HepB BD) vaccine. This groundbreaking initiative, launched in November 2025, marks a turning point in the country's battle against this preventable disease.

A Devastating Cycle Broken:

Hepatitis B transmission from mother to child is a leading cause of chronic infection in Ethiopia. Shockingly, up to 90% of infants infected at birth face a lifetime of health struggles. This isn't just a statistic; it's a heartbreaking reality for countless families. The HepB BD vaccine, administered within 24 hours of birth, acts as a shield, breaking this devastating cycle. Countries that have embraced this vaccine have witnessed a dramatic decline in childhood Hepatitis B cases, proving its effectiveness in elimination efforts.

A Nationwide Effort, A Global Partnership:

Ethiopia's ambitious rollout targets all 3.8 million newborns annually, aiming for at least 80% national coverage. This massive undertaking is fueled by a strong partnership with the World Health Organization (WHO), Gavi, the Vaccine Alliance, UNICEF, and other dedicated immunization partners. Their support extends beyond funding; it encompasses technical expertise, training, and logistical assistance.

Preparation is Key:

Ethiopia didn't just flip a switch. A comprehensive Training of Trainers program equipped over 100 health officers with the knowledge and skills to lead the rollout across regions. Cascade training, supported by WHO, UNICEF, and partners, ensured that every level of the healthcare system was prepared for vaccine delivery, cold-chain management, data reporting, and other crucial aspects of successful immunization.

Addressing Challenges, Ensuring Success:

Pilot programs in three regions identified potential roadblocks, allowing for a refined and feasible national rollout plan. The Ministry of Health played a pivotal role, developing standardized training manuals and securing funding from Gavi. A remarkable 97% score on the National Readiness Assessment Tool underscores Ethiopia's commitment and preparedness.

A Safe and Essential Shield:

Dr. Dereje Duguma, State Minister of Health, emphasized the vaccine's safety and efficacy, urging parents and communities to ensure every child receives this life-saving protection. With the HepB BD vaccine, Ethiopia now offers 15 routine vaccines, a testament to its dedication to child health.

A Collective Victory:

This initiative is more than just a medical advancement; it's a beacon of hope. As Dr. Kasolo, WHO Representative to Ethiopia, stated, it's a critical step towards eliminating mother-to-child transmission of Hepatitis B, paving the way for healthier futures for Ethiopian families. Gavi's Emmanuella Baguma highlighted the transformative impact on child health, while UNICEF's Dr. Aboubacar Kampo stressed the vaccine's role in giving every child a healthy start.

The Road Ahead:

WHO, UNICEF, and Gavi remain steadfast partners, providing ongoing support throughout the rollout phase. This includes technical and financial assistance for the launch, supervision, and a Post Introduction Evaluation to ensure continuous improvement.

A Question for Reflection:

Ethiopia's bold move raises a crucial question: How can we ensure equitable access to life-saving vaccines like HepB BD for all children, regardless of their geographical location or socioeconomic status? Let's continue this important conversation in the comments below.

Media Contacts:

For more information, please contact:

  • Meg Sharafudeen, Gavi: +41 79 711 55 54, msharafudeen@gavi.org
  • Collins Weru Mwai, Gavi: +25 078 783 66 38, cmwai@gavi.org
  • Melkamu Ayalew, MoH Ethiopia (EPI Manager): melkamu.ayalew@moh.gov.et
  • Selamawit Yilma, WHO Ethiopia (Knowledge Management and Communication Officer): yilmas@who.int
  • Wossen Mulatu, UNICEF (Communication Specialist): wmulatu@unicef.org, 0911308483
Ethiopia Launches Hepatitis B Birth Dose Vaccine to Protect Newborns (2026)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Prof. Nancy Dach

Last Updated:

Views: 6200

Rating: 4.7 / 5 (77 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Prof. Nancy Dach

Birthday: 1993-08-23

Address: 569 Waelchi Ports, South Blainebury, LA 11589

Phone: +9958996486049

Job: Sales Manager

Hobby: Web surfing, Scuba diving, Mountaineering, Writing, Sailing, Dance, Blacksmithing

Introduction: My name is Prof. Nancy Dach, I am a lively, joyous, courageous, lovely, tender, charming, open person who loves writing and wants to share my knowledge and understanding with you.